| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |